诺普拉桑在非侵蚀性反流性疾病中有效治疗心烧:一项随机试验
Loren Laine1, Stuart Spechler2, Rena Yadlapati3
1Yale School of Medicine, New Haven, Connecticut; VA Connecticut Healthcare System, West Haven, Connecticut.
诺普拉桑有效地减少了非侵蚀性反流性疾病患者的胃灼热症状,显示出快速和持续的缓解. 两种10毫克和20毫克剂量都显示出类似的疗效,从治疗的第一天就观察到好处.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 竞争性酸阻断剂 (P-CABs) 对侵蚀性食道炎有效.
- 非侵蚀性反流性疾病 (NERD) 影响了许多患有胃灼热的人.
- 在NERD中P-CABs的有效性需要进一步研究.
研究的目的:
- 评估vonoprazan在治疗NERD患者的胃灼热症状中的疗效.
- 为了比较vonoprazan (10 mg和20 mg) 与安慰剂的症状缓解.
- 为了评估vonoprazan在20周的延长期内效果的持久性.
主要方法:
- 一个为期4周的随机,安慰剂对照试验,随后是20周的活性治疗延期.
- 参与研究的是患有经常性胃烧 (≥4天/周) 且没有侵蚀性食道炎的成年人.
- 主要终点是24小时无日的百分比.
主要成果:
- 与安慰剂相比,vonoprazan显著增加了没有烧的日子 (10 mg: 44.8%,20 mg: 44.4%与安慰剂相比: 27.7%).
- 早在治疗的第一天就观察到症状的改善.
- 在整个20周的延长期内,人们注意到持续的疗效,治疗手臂的结果相似.
结论:
- 诺普拉桑是一种有效的治疗方法,可减少NERD患者的胃灼热症状.
- 诺普拉桑的治疗益处迅速出现,并随着时间的推移而持续.
- 诺普拉桑的10毫克和20毫克剂量都显示出可比的疗效.
更多相关视频
00:04A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
06:12Evaluation of the Efficacy of the H. pylori Protein HP-NAP as a Therapeutic Tool for Treatment of Bladder Cancer in an Orthotopic Murine Model
Published on: May 29, 2015
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
